IP Library Granted Patent US 7,122,189
Granted Patent B2
US 7,122,189 · App. 10/218,167 · Granted Oct 17, 2006

Releasable polymeric conjugates based on aliphatic biodegradable linkers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,122,189
App. No.
10/218,167
Granted
Oct 17, 2006
Kind
B2
Abstract

Activated polymeric bicine derivatives such as as well as conjugates made therewith are disclosed. Methods of making and using the bicine derivatives are also disclosed.

Claims (131)

1. A compound comprising the Formula (I):

wherein:

R 1 and R 2 are independently selected from the group consisting of substantially non-antigenic polymer residues, C 1-6 alkyls, aralkyls, and terminal branching groups;

Y 1-3 are independently O, S or NR 11 ;

L 1 and L 2 are independently selected bifunctional linkers;

Z is selected from the group consisting of

 wherein L 3 is a bifunctional linker and Y 4 is O, S or NR 11 , hydrophobic moieties, bifunctional linking moieties and combinations thereof;

R 3 –R 11 , R 24 and R 25 are independently selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy;

A is selected from the group consisting of leaving groups, functional groups, and OH;

a and c are each independently 0 or a positive integer:

b, d and e are independently 0 or 1; and

m, n, o, and p are independently selected positive integers, provided that a and b are both not 0 when c and d are both 0.

2. The compound of claim 1 , wherein R 3 –R 10 , R 24 and R 25 are each hydrogen.

3. The compound of claim 1 , wherein a, b, c, d, m, n, o and p are each 1 and e is 0 or 1.

4. The compound of claim 1 , wherein R 1 comprises a polyalkylene oxide.

5. The compound of claim 1 , wherein R 2 comprises a polyalkylene oxide.

6. The compound of claim 1 , wherein R 1 comprises a polyethylene glycol.

7. The compound of claim 1 wherein R 2 comprises a polyethylene glycol.

8. The compound of claim 1 wherein R 1 or R 2 further include a capping group J, selected from the group consisting of OH, NH 2 , SH, CO 2 H, C 1-6 alkyl moieties,

9. A compound of claim 8 , selected from the group consisting of:

wherein L 3 is a bifunctional linker and Y 4 is O, S or NR 11 .

10. The compound of claim 1 , wherein R 1 is selected from the group consisting of:

J-O—(CH 2 CH 2 O) x —,

J-O—(CH 2 CH 2 O) x —CH 2 C(O)—O—,

J-O—(CH 2 CH 2 O) x —CH 2 CH 2 NR 12 —,

J-O—(CH 2 CH 2 O) x —CH 2 CH 2 SH—,

—OC(O)CH 2 —O—(CH 2 CH 2 O) X —CH 2 C(O)—O—,

—NR 12 CH 2 CH 2 —O—(CH 2 CH 2 O) X —CH 2 CH 2 NR 12 — and

—SHCH 2 CH 2 —O—(CH 2 CH 2 O) X —CH 2 CH 2 SH—

wherein:

x is the degree of polymerization;

R 12 is selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy; and

J is a capping group.

11. The compound of claim 1 , wherein R 1 and R 2 are individually selected from the group consisting of:

CH 3 —O—(CH 2 CH 2 O) x —, CH 3 —O—(CH 2 CH 2 O) x —CH 2 C(O)—O—,

CH 3 —O—(CH 2 CH 2 O) x —CH 2 CH 2 NH— and CH 3 —O—(CH 2 CH 2 O) x —CH 2 CH 2 SH—

wherein x is the degree of polymerization.

12. The compound of claim 10 , wherein R 2 is selected from the group consisting of:

J-O—(CH 2 CH 2 O) x —,

J-O—(CH 2 CH 2 O) x —CH 2 C(O)—O—,

J-O—(CH 2 CH 2 O) x —CH 2 CH 2 NR 13 —,

J-O—(CH 2 CH 2 O) x —CH 2 CH 2 SH—,

—OC(O)CH 2 —O—(CH 2 CH 2 O) X —CH 2 C(O)—O—,

—NR 13 CH 2 CH 2 —O—(CH 2 CH 2 O) X —CH 2 CH 2 NR 13 — and

—SHCH 2 CH 2 —O—(CH 2 CH 2 O) X —CH 2 CH 2 SH—,

wherein:

x is the degree of polymerization;

R 13 is selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy and

J is a capping group.

13. The compound of claim 1 , wherein R 1 and R 2 each comprise a polymer residue of the formula —O—(CH 2 CH 2 O) x .

14. The compound of claim 13 , wherein R 1 and R 2 each have a weight average molecular weight of from about 2,000 Da to about 25,000 Da.

15. The compound of claim 1 wherein L 1 is selected from the group consisting of:

—NH(CH 2 CH 2 O) 2 CH 2 C(O)—,

—NH(CH 2 ) 3 OC(O)—,

—(CH 2 ) t C(O)—,

—C(O)NH(CH 2 ) t C(O)—,

—NH(CH 2 ) t C(O)—,

—NR 19 (CH 2 ) t (CH 2 CH 2 O) q NHC(O)—,

—(CH 2 CH 2 O) t NHC(O)—,

—O(CR 14 R 15 ) t NHC(O)—,

—NR 19 (CR 14 R 15 ) q C(O)NH(CR 16 R 17 ) t C(O)—,

—O(CH 2 ) t OC(O)—,

—NR 19 (CR 14 R 15 ) t C(O)—,

—NR 19 (CH 2 ) t (CH 2 CH 2 O) q NHC(O)—,

—NR 19 (CH 2 CH 2 O) t —OC(O)—,

—O(CR 14 R 15 ) t NHC(O)—,

—O(CR 14 R 15 ) t OC(O)—,

—(CH 2 CH 2 O) t NHC(O)—,

wherein

R 14 –R 17 and R 19 are independently selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy;

R 18 is selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy, NO 2 , haloalkyl and halogen; and

t and q are individually selected positive integers.

16. The compound of claim 1 wherein L 2 is selected from the group consisting of:

—NH(CH 2 CH 2 O) 2 CH 2 C(O)—,

—NH(CH 2 ) 3 OC(O)—,

—(CH 2 ) v C(O)—,

—C(O)(CH 2 ) v NHC(O)—,

—NH(CH 2 ) v C(O)—,

—NR 25 (CH 2 ) v (CH 2 CH 2 O) w NHC(O)—,

—(CH 2 CH 2 O) v NHC(O)—,

—O(CR 20 R 21 ) v NHC(O)—,

—NR 25 (CR 20 R 21 ) w (O)CNH(CR 22 C 23 ) v C(O)—,

—O(CH 2 ) v OC(O)—,

—NR 25 (CR 20 R 21 ) v C(O)—,

—NR 25 (CH 2 ) v (CH 2 CH 2 O) w NHC(O)—,

—NR 25 (CH 2 CH 2 O) v —O—C(O)

—O(CR 20 R 21 ) v NHC(O)—,

—O(CR 20 R 21 ) v OC(O)—,

—(CH 2 CH 2 O) v NHC(O)—,

wherein

R 20 –R 23 and R 25 are independently selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy;

R 24 is selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy, C 1-6 heteroalkoxy, NO 2 , haloalkyl and halogen; and

v and w are individually selected positive integers.

17. A compound of claim 1 , comprising the formula:

18. A compound of claim 1 , selected from the group consisting of:

where A 1 is a leaving group.

19. The compound of claim 1 , wherein A 1 is a leaving group selected from the group consisting of

20. The compound of claim 1 , wherein A is selected from the group consisting of maleimidyl, vinyl, residues of sulfone, hydroxy, amino, carboxy, mercapto, hydrazide, and carbazate functional groups.

21. The compound of claim 20 , wherein A is:

22. The compound of claim 1 , wherein said terminal branching group comprises the formula:

wherein:

Y 5 is O, S or NR 46 ;

L 4 is a bifunctional linker;

R 40 –R 46 are independently selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy;

j and k are each independently 0 or a positive integer;

q is 0 or 1;

g, h, v and w are independently selected positive integers;

R 50 is selected from the group consisting of substantially non-antigenic polymer residues, C 1-6 alkyls, C 1-6 aralkyls, and

wherein:

L 5 is a bifunctional linker;

R 60 is selected from the group consisting of substantially non-antigenic polymer residues, C 1-6 alkyls and C 1-6 aralkyls.

23. A compound of claim 22 , comprising the structure:

24. A compound of claim 22 , comprising the structure:

25. A compound of claim 1 , selected from the group consisting of

26. A compound of claim 1 , selected from the group consisting of

27. A method of preparing a polymer conjugate, comprising reacting a compound of the formula:

wherein:

A 1 is a leaving group;

R 1 and R 2 are independently selected from the group consisting of substantially non-antigenic polymer residues, C 1-6 alkyls, aralkyls, and terminal branching groups;

Y 1-3 are independently O, S or NR 11 ;

L 1 and L 2 are independently selected bifunctional linkers;

Z is selected from

 wherein L 3 is a bifunctional linker and Y4 is O, S or NR 11 , hydrophobic moieties, bifunctional linking moieties and combinations thereof;

R 3 –R 11 , R 24 and R 25 are independently selected from the group consisting of hydrogen, C 1-6 alkyls, C 3-19 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy;

with an amine-containing, biologically active agent under conditions sufficient to form

wherein A 2 is a residue of an amine containing biologically active agent selected from the group consisting of proteins, enzymes, peptides, polypeptides, peptide nucleic acids and nucleic acids.

28. A method of preparing a bicine-based polymer transport system, comprising

a) synthesizing an acid protected bicine;

b) attaching a blocked bifunctional spacer to each hydroxyl of the acid protected bicine;

c) deprotecting the resultant intermediate and reacting it with an activated polymer under basic coupling conditions; and

d) deprotecting and activating the blocked acid of said acid protected bicine under coupling conditions.

Assignments (2)
CHANGE OF ADDRESS Recorded Feb 3, 2014
From: BELROSE PHARMA INC.
To: BELROSE PHARMA INC.
Reel/Frame 032152/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2013
From: ENZON PHARMACEUTICALS, INC.
To: BELROSE PHARMA, INC.
Reel/Frame 030982/0692 →